HOB Biotech Group Corp.,Ltd

¥102.00As of Sun 8 Nov 2026, 12:00 UTC
SSE:688656Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR 3.70%
Div yield 0.20%
ROE 3.12%
Medical Devices
Beta (5Y) (0.15)
PE TTM 247.4
TSR TTM (37.83%)
Mkt cap ¥6.397B
ROIC 3.64%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥100
(1.69%)
4.03%
Hold 5|4|8|12|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
2.39
2.54
2.79
2.88
9.81%
7.59%
21.46%
16.04%
Revenue¥M
378.8
384.4
405.9
393.9
2.35%
6.61%
6.38%
4.20%
Peers (US$959.0M)
Cap (US$)
PE
954.4M
111.0x
Capital
TTM
5Y
10Y
Leveragex
0.768
—
—
EBIT/Intx
3.336
0.787
0.634
Own earn%
52.09
10.72
18.63
Sh yield%
31.68
22.08
21.08
Owners
Insiders/Inst%
13.47
42.54
Short interest%
3.61
SBC / revenue%
5.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
25–32
$1 testx
—
Incr. ROIC%
41